Estimating HIV cross-sectional incidence using recency tests from a non-representative sample
American Journal of Epidemiology · 04.11.2026 · 195 (11) · 2847-2853
DOI: 10.1093/aje/kwag075 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift American Journal of Epidemiology, online erschienen am 06.04.2026. Verfasst von Jianan Pan und 2 weiteren Autor:innen. Beteiligte Einrichtung: Biostatistics, University of Washington School of Public Health, Seattle, WA, United States. Hauptthemen laut MEDLINE: HIV Infections. Die Arbeit nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIAID NIH HHS.
Abstract (Originalsprache)
Cross-sectional incidence estimation based on recency testing is a widely used tool in HIV research. This method has been used to estimate “placebo” incidence in active-control HIV prevention trials by applying the cross-sectional estimator to the screening population data. The application of this approach faces challenges due to nonrepresentative sampling, as individuals aware of their HIV-positive status may be less likely to participate in screening for an HIV prevention trial. To address this, recent phase 3 trials introduced a test-based criterion, excluding individuals who had recently taken an HIV test. To date, the theoretical and empirical validity of this criterion has yet to be studied. We develop a statistical framework incorporating nonrepresentative sampling and the testing-based criterion. We quantify the limiting estimation error in recency-based incidence estimates, and investigate the performance of cross-sectional HIV incidence estimation through simulations emulating real-world trial designs. We find that under nonrepresentative sampling, the incidence estimator is unreliable unless all recently tested individuals are excluded. Additionally, we highlight a bias-variance trade-off: excluding more individuals may reduce estimation bias from nonrepresentative sampling but increases the variability. Our findings emphasize careful application of the testing-based criterion and the importance of improved methods in future HIV prevention trials.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Biostatistics, University of Washington School of Public Health, Seattle, WA, United States.
- Biostatistics, Bioinformatics and Epidemiology Program, Fred Hutchinson Cancer Research Center, Seattle, WA, United States.
- Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States.
Förderung
- NIAID NIH HHS
Zitieren
APA
Pan, J., Bannick, M., & Gao, F. (2026). Estimating HIV cross-sectional incidence using recency tests from a non-representative sample. American Journal of Epidemiology, 195(11), 2847-2853. https://doi.org/10.1093/aje/kwag075
Vancouver
Pan J, Bannick M, Gao F. Estimating HIV cross-sectional incidence using recency tests from a non-representative sample. American Journal of Epidemiology. 2026;195(11):2847-2853. doi:10.1093/aje/kwag075
BibTeX
@article{Pan2026,
author = {Pan, Jianan and Bannick, Marlena and Gao, Fei},
title = {Estimating HIV cross-sectional incidence using recency tests from a non-representative sample},
journal = {American Journal of Epidemiology},
year = {2026},
volume = {195},
number = {11},
pages = {2847--2853},
doi = {10.1093/aje/kwag075}
}
EUVIMED